This milestone represents an important step in expanding access and reducing barriers to at-home management for people affected by severe urinary incontinence in the U.S. The Surity™ portfolio provides non-invasive management solutions for individuals living with urinary incontinence and is designed to make everyday urine management more comfortable, discreet and reliable. Coding verification under Healthcare Common Procedure Coding System (HCPCS) codes A6590 for the Surity™ Female and Male External Catheters and E2001 for the Surity™ Urinary Management System supports reimbursement access for beneficiaries who meet applicable coverage criteria.

For the more than 13 million people living with urinary incontinence in the U.S.,i access to management solutions that address care needs like comfort and rest can have meaningful impact. Traditional Medicare reimbursement access for the Surity™ portfolio helps provide eligible beneficiaries with a new choice, combining gentle suction technology with an intuitive design and features that support quiet operation and odor management, assisting in overnight care and bringing added reassurance to daily routines.

Following the introduction of the Surity™ Female and Male External Catheters earlier in 2026, Wellspect launched the Surity™ Urinary Management System in the United States on August 18, completing the full Surity portfolio. Since its introduction, Surity has become one of the most searched external catheter brands on Google.ii